COPD and air travel: does hypoxia-altitude simulation testing predict in-flight respiratory symptoms?

The reduced pressure in an aircraft cabin may cause significant hypoxaemia and respiratory symptoms in patients with chronic obstructive pulmonary disease (COPD). The current study evaluated whether there is a relationship between hypoxaemia obtained during hypoxia-altitude simulation testing (HAST), simulating an altitude of 2438 m, and the reporting of respiratory symptoms during air travel. 82 patients with moderate to very severe COPD answered an air travel questionnaire.

Arterial oxygen pressure following whole-body vibration at altitude.

Introduction: Most helicopter operations are carried out at altitudes below 10,000 ft. At these altitudes, the risk of the crew experiencing hypoxia is low. For that reason, supplementary oxygen is not standard equipment on board most helicopters.